Name : TMIGD1 Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :263
SKU : GEN2549308151
| Long name | TMIGD1 Primary Polyclonal Antibody |
| Also known as | TMIGD1 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | TMIGD1 |
| Specificity | This is a highly specific antibody against TMIGD1 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Immunogen range | 160-200/262 |
| Subcellular location | Extracellular |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human TMIGD1 |
| Gene ID number | 388364 |
| Swiss Prot | Q6UXZ0 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | Alexander disease, BRCA1 is directly involved in DNA repair, Birt-Hogg-DubÃ, Chromosome 17 is also linked to neurofibromatosis, Like p53, Malfunction or loss of p53 expression is associated with malignant cell growth and Li-Fraumeni syndrome, Tumor suppressor p53 is necessary for maintenance of cellular genetic integrity by moderating cell fate through DNA repair versus cell death, Two key tumor suppressor genes are associated with chromosome 17, a condition characterized by neural and epidermal lesions, and dysregulated Schwann cell growth, colon, namely, p53 and BRCA1, prostate gland and fallopian tubes, syndrome and Canavan disease are also associated with chromosome 17, though specifically it is recognized as a genetic determinant of early onset breast cancer and predisposition to cancers of the ovary, ©, 200 genes, 5% of the human genome with about 81 million bases encoding over 1, Chromosome 17 makes up over 2 |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | TMIGD1, Transmembrane and immunoglobulin domain-containing protein 1, UNQ9372, UNQ9372/PRO34164, TMIGD |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | TMIGD1 |
| Short name | TMIGD1 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | transmembrane and immunoglobulin domain containing 1 (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | BT, Plasma membranes, TMIGD1 and IDBG-38931 and ENSG00000182271 and 388364, Tmigd1 and IDBG-201228 and ENSMUSG00000020839 and 66601, protein binding, this GO :0005515 and protein binding and molecular function this GO :0016021 and integral component of membrane and cellular component, this GO :0005515: protein binding, this GO :0005515: protein binding, 49016 and IDBG-632511 and ENSBTAG00000002609 and 506345, transmembrane and immunoglobulin domain containing 1 |
| Identity | 32431 |
| Gene | TMIGD1 |
| Long gene name | transmembrane and immunoglobulin domain containing 1 |
| Synonyms gene | TMIGD |
| Synonyms | UNQ9372 |
| Locus | 17q11, 2 |
| Discovery year | 2005-12-19 |
| GenBank acession | AY358153 |
| Entrez gene record | 388364 |
| Pubmed identfication | 12975309 26342724 |
| RefSeq identity | NM_206832 |
| Classification | I-set domain containing Immunoglobulin like domain containing |
| Havana BLAST/BLAT | OTTHUMG00000179757 |